[ adverts ]
| 27/08/2008 |
| Daily Telegraph |
| By: Presswatch |
| Toxic metals in Ayurvedic remedies |
| A study by Boston University School of Medicine has found that traditional Indian remedies sold on the internet often contain levels of lead, mercury and arsenic exceeding acceptable standards. Researchers analysed 193 randomly selected Ayurvedic medicine products. Several could result in people consuming lead and mercury between 100 and 10,000 times the acceptable limits, the team said in the Journal of the American Medical Association. |
|
[ linebreak ]
|
| 27/08/2008 |
| Daily Telegraph |
| By: Presswatch |
| Drug for Parkinson's can slow progression of disease |
| People with Parkinson's disease have been offered new hope after the drug rasagiline, also known as Azilect, used in research, appeared to slow the progression of the brain disease for the first time. A study by Newcastle University found that patients who took the medication soon after diagnosis had a less aggressive form of the condition than those who did not take it until later. |
|
[ linebreak ]
|
| 27/08/2008 |
| The Times |
| By: Presswatch |
| Regulator has Sandoz manufacturing concerns |
| US regulators have warned Sandoz, the generic drug unit of Novartis, the Swiss pharmaceuticals group, about manufacturing problems at a North Carolina plant. Food and Drug Administration inspectors found that it had failed to validate properly the manufacturing process for metoprolol succinate ER tablets, a generic form of AstraZeneca's Toprol XL blood pressure treatment. |
|
[ linebreak ]
|
| 27/08/2008 |
| Daily Telegraph |
| By: Presswatch |
| Hidden risk of skin cancer |
| Patients who have beaten non-melanoma skin cancer are far more likely than other people to be diagnosed with another type of cancer within two decades, according to findings published in the Journal of the National Cancer Institute. The risks were found to increase the younger a patient was when diagnosed with skin cancer. |
|
[ linebreak ]
|
| 27/08/2008 |
| Financial Times |
| By: Presswatch |
| Eyesight hope after drug U-turn |
| Patients suffering from the most common cause of progressive blindness in the elderly should soon get an expensive drug on the NHS. The National Institute for Health and Clinical Excellence has given clearance to use Lucentis for wet age-related macular degeneration. It costs about £10,700 per patient. Novartis is to pay for provision if people need further treatment after 14 injections. |
|
[ linebreak ]
|
| 27/08/2008 |
| Daily Telegraph |
| By: Presswatch |
| Children aged 10 to be screened for cholesterol |
| Relatives of people with a medical condition that causes heart attacks will be screened for it, health watchdog Nice revealed yesterday. Experts hope to identify up to 100,000 people with familial hypercholesterolaemia (FH) - a treatable genetic defect which causes artery-narrowing levels of cholesterol. |
|
[ linebreak ]
|
| 27/08/2008 |
| By: Presswatch |
| NHS and Health Sector News |
| The Daily Telegraph reports that the NHS fraud squad is investigating a website that sells fake doctors' sick notes for £25 each. The documents are almost identical to a genuine letter from a GP or hospital, and are printed with real doctors' names and feature notes that are stamped and signed. The Sun reports that Professor Paul Goddard, one of Britain's most senior medics, yesterday claimed thousands of hospital patients are starving because nurses are too busy to feed them. |
|
[ linebreak ]
|
| [ End of selection ] |
| Top of the page |